{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:48:48Z","timestamp":1693716528760},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,31]],"date-time":"2010-03-31T00:00:00Z","timestamp":1269993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00280-010-1312-2","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T07:18:28Z","timestamp":1269933508000},"page":"191-195","source":"Crossref","is-referenced-by-count":8,"title":["A phase I\/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie"],"prefix":"10.1007","volume":"66","author":[{"given":"Volker","family":"Kaechele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Moehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred P.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goetz","family":"von Wichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Eisele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Galle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Seufferlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,31]]},"reference":[{"key":"1312_CR1","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographical regions of the world. J Clin Oncol 24:2137\u20132150. doi: 10.1200\/JCO.2005.05.2308","journal-title":"J Clin Oncol"},{"key":"1312_CR2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/gut.46.6.754","volume":"46","author":"AJ Cameron","year":"2000","unstructured":"Cameron AJ, Romero Y (2000) Symptomatic gastro-oesophageal reflux as a risk factor for oesophageal adenocarcinoma. Gut 46:754\u2013755","journal-title":"Gut"},{"key":"1312_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","volume":"358","author":"D Cunningham","year":"2008","unstructured":"Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358:36\u201346","journal-title":"N Engl J Med"},{"key":"1312_CR4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1200\/JCO.2007.13.9378","volume":"26","author":"SE Al-Batran","year":"2008","unstructured":"Al-Batran SE, Hartmann JT, Probst S, Schmalenberg H, Hollerbach S, Hofheinz R, Rethwisch V, Seipelt G, Homann N, Wilhelm G, Schuch G, Stoehlmacher J, Derigs HG, Hegewisch-Becker S, Grossmann J, Pauligk C, Atmaca A, Bokemeyer C, Knuth A, Jaeger E (2008) Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the AIO. J Clin Oncol 26:1435\u20131442. doi: 10.1200\/JCO.2007.13.9378","journal-title":"J Clin Oncol"},{"key":"1312_CR5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/annonc\/mdm004","volume":"1","author":"DH Ilson","year":"2007","unstructured":"Ilson DH, Wadleigh RG, Leichman LP, Kelsen DP (2007) Paclitaxel given by a weekly 1-h infusion in advanced oesophageal cancer. Ann Oncol 1:898\u2013902. doi: 10.1093\/annonc\/mdm004","journal-title":"Ann Oncol"},{"key":"1312_CR6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/annonc\/mdh230","volume":"15","author":"BF El-Rayes","year":"2004","unstructured":"El-Rayes BF, Shields A, Zalupski M, Heilbrun LK, Jain V, Terry D, Ferris A, Philip PA (2004) A phase II study of carboplatin and paclitaxel in oesophageal cancer. Ann Oncol 15:960\u2013965. doi: 10.1093\/annonc\/mdh230","journal-title":"Ann Oncol"},{"issue":"10","key":"1312_CR7","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdm269","volume":"18","author":"S Lorenzen","year":"2007","unstructured":"Lorenzen S, Hentrich M, Haberl C, Heinemann V, Schuster T, Seroneit T, Roethling N, Peschel C, Lordick F (2007) Split-dose docetaxel, cisplatin and leucovorin\/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial. Ann Oncol 18(10):1673\u20131679","journal-title":"Ann Oncol"},{"issue":"31","key":"1312_CR8","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","volume":"24","author":"E Cutsem Van","year":"2006","unstructured":"Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse EL, Ajani JA (2006) Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 24(31):4991\u20134997","journal-title":"J Clin Oncol"},{"issue":"8","key":"1312_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jjco\/hyi130","volume":"35","author":"Y Fujie","year":"2005","unstructured":"Fujie Y, Yamamoto H, Ngan CY, Takagi A, Hayashi T, Suzuki R, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M (2005) Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells. Jpn J Clin Oncol 35(8):453\u2013463","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"1312_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000095826","volume":"74","author":"J Gu","year":"2006","unstructured":"Gu J, Yamamoto H, Lu X, Ngan CY, Tsujino T, Konishi K, Takemasa I, Ikeda M, Nagata H, Hashimoto S, Matsuzaki T, Sekimoto M, Takagi A, Monden M (2006) Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines. Digestion 74(1):19\u201327","journal-title":"Digestion"},{"issue":"4","key":"1312_CR11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/bjc.1998.524","volume":"78","author":"S Petrasch","year":"1998","unstructured":"Petrasch S, Welt A, Reinacher A, Graeven U, Konig M, Schmiegel W (1998) Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer. Br J Cancer 78(4):511\u2013514","journal-title":"Br J Cancer"},{"issue":"3","key":"1312_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumours: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205\u2013216","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1312_CR13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1200\/JCO.1999.17.6.1751","volume":"17","author":"E Wassermann","year":"1999","unstructured":"Wassermann E, Cuvier C, Lokiec, Goldwasser F, Kalla S, M\u00e9ry-Mignard D, Ouldkaci M, Besmaine A, Dupont-Andr\u00e9 G, Mahjoubi M, Marty M, Misset JL, Cvitkovic E (1999) Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumours: results of two independent phase I studies with pharmacokinetics. J Clin Oncol 17(6):1751\u20131759","journal-title":"J Clin Oncol"},{"issue":"11","key":"1312_CR14","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1200\/JCO.1999.17.11.3560","volume":"17","author":"T Andr\u00e9","year":"1999","unstructured":"Andr\u00e9 T, Bensmaine MA, Louvet C, Fran\u00e7ois E, Lucas V, Desseigne F, Beerblock K, Bouch\u00e9 O, Carola E, Merrouche Y, Morvan F, Dupont-Andr\u00e9 G, de Gramont A (1999) Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 17(11):3560\u20133568","journal-title":"J Clin Oncol"},{"issue":"1","key":"1312_CR15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/annonc\/mdm449","volume":"19","author":"D Richards","year":"2008","unstructured":"Richards D, McCollum D, Wilfong L, Sborov M, Boehm KA, Zhan F, Asmar L (2008) Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and\/or adenocarcinoma of the gastroesophageal junction. Ann Oncol 19(1):104\u2013108","journal-title":"Ann Oncol"},{"issue":"6","key":"1312_CR16","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1158\/1078-0432.CCR-03-0319","volume":"10","author":"MB Polee","year":"2004","unstructured":"Polee MB, Sparreboom A, Eskens FA, Hoekstra R, van de Schaaf J, Verweij J, Stoter G, van der Gaast A (2004) A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancer. Clin Cancer Res 10(6):1928\u20131934","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1312_CR17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/annonc\/mdg328","volume":"14","author":"MB Polee","year":"2003","unstructured":"Polee MB, Tilanus HW, Eskens FA, Hoekstra R, Van der Burg ME, Siersema PD, Stoter G, Van der Gaast A (2003) Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2\u00a0weeks for patients with a resectable squamous cell carcinoma of the esophagus. Ann Oncol 14(8):1253\u20131257","journal-title":"Ann Oncol"},{"issue":"6","key":"1312_CR18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/annonc\/mdh215","volume":"15","author":"JD Winegarden","year":"2004","unstructured":"Winegarden JD, Mauer AM, Otterson GA, Rudin CM, Villalona-Calero MA, Lanzotti VJ, Szeto L, Kasza K, Hoffman PC, Vokes EE (2004) A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer. Ann Oncol 15(6):915\u2013920","journal-title":"Ann Oncol"},{"issue":"3","key":"1312_CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/annonc\/mdj097","volume":"17","author":"P Viens","year":"2006","unstructured":"Viens P, Petit T, Yovine A, Bougnoux P, Deplanque G, Cottu PH, Delva R, Lotz JP, Belle SV, Extra JM, Cvitkovic E (2006) A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients. Ann Oncol 17(3):429\u2013436","journal-title":"Ann Oncol"},{"issue":"6","key":"1312_CR20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1179\/joc.2008.20.6.744","volume":"20","author":"RB Lin","year":"2008","unstructured":"Lin RB, Fan NF, Guo ZQ, Wang XJ, Liu J, Chen L (2008) A phase II study of 5-fluorouracil\/leucovorin in combination with paclitaxel and oxaliplatin as first-line treatment for patients with advanced gastric cancer. J Chemother 20(6):744\u2013748","journal-title":"J Chemother"},{"issue":"6","key":"1312_CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00280-004-0966-z","volume":"55","author":"R Tanaka","year":"2005","unstructured":"Tanaka R, Ariyama H, Qin B, Takii Y, Baba E, Mitsugi K, Harada M, Nakano S (2005) In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines. Cancer Chemother Pharmacol 55(6):595\u2013601","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"1312_CR22","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1158\/1078-0432.CCR-07-4903","volume":"14","author":"TS Bekaii-Saab","year":"2008","unstructured":"Bekaii-Saab TS, Lui J, Chan KK, Balcerzak SP, Ivy P, Grever MR, Kraut EH (2008) A phase I and pharmacokinetic study of weekly oxaliplatin followed by paclitaxel. Clin Cancer Res 14(11):3434\u20133440","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1312-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-010-1312-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1312-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T06:07:07Z","timestamp":1559023627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-010-1312-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,31]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["1312"],"URL":"https:\/\/doi.org\/10.1007\/s00280-010-1312-2","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,31]]}}}